X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (55093) 55093
Book Review (9082) 9082
Newsletter (6708) 6708
Publication (4116) 4116
Conference Proceeding (570) 570
Book Chapter (256) 256
Dissertation (242) 242
Magazine Article (174) 174
Newspaper Article (123) 123
Book / eBook (51) 51
Web Resource (47) 47
Trade Publication Article (20) 20
Journal / eJournal (14) 14
Reference (14) 14
Paper (12) 12
Government Document (8) 8
Presentation (3) 3
Data Set (2) 2
Streaming Video (2) 2
Transcript (2) 2
Poster (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (40459) 40459
humans (36627) 36627
helicobacter pylori (36316) 36316
male (18642) 18642
female (18215) 18215
middle aged (14339) 14339
gastroenterology & hepatology (13466) 13466
adult (12973) 12973
infection (12197) 12197
aged (10314) 10314
helicobacter infections (10314) 10314
helicobacter infections - drug therapy (8615) 8615
helicobacter infections - complications (8258) 8258
research (7506) 7506
helicobacter infections - microbiology (7406) 7406
helicobacter pylori - isolation & purification (7099) 7099
helicobacter-pylori (6958) 6958
microbiology (6627) 6627
helicobacter-pylori infection (6590) 6590
animals (6517) 6517
risk factors (6143) 6143
cancer (5907) 5907
health aspects (5858) 5858
helicobacter infections - diagnosis (5548) 5548
prevalence (5204) 5204
stomach cancer (4889) 4889
adolescent (4740) 4740
gastritis (4692) 4692
abridged index medicus (4686) 4686
eradication (4651) 4651
helicobacter infections - epidemiology (4594) 4594
helicobacter pylori - drug effects (4122) 4122
helicobacter pylori - immunology (4048) 4048
gastritis - microbiology (3987) 3987
oncology (3935) 3935
helicobacter infections - pathology (3896) 3896
aged, 80 and over (3799) 3799
gastric cancer (3745) 3745
helicobacter pylori - pathogenicity (3734) 3734
helicobacter pylori - genetics (3706) 3706
anti-bacterial agents - therapeutic use (3617) 3617
analysis (3534) 3534
gastric mucosa - pathology (3519) 3519
child (3323) 3323
drug therapy, combination (3294) 3294
gastric mucosa - microbiology (3276) 3276
disease (3251) 3251
immunology (3150) 3150
medical research (3087) 3087
biopsy (3042) 3042
infections (3042) 3042
pharmacology & pharmacy (3039) 3039
diagnosis (3018) 3018
stomach neoplasms - microbiology (3016) 3016
risk (2969) 2969
medicine, general & internal (2914) 2914
mice (2899) 2899
treatment outcome (2827) 2827
helicobacter infections - immunology (2812) 2812
bacteria (2768) 2768
infectious diseases (2760) 2760
stomach (2744) 2744
epidemiology (2707) 2707
stomach neoplasms - pathology (2706) 2706
medicine, experimental (2635) 2635
inflammation (2632) 2632
prospective studies (2582) 2582
expression (2560) 2560
duodenal-ulcer (2475) 2475
care and treatment (2465) 2465
genetic aspects (2353) 2353
children (2295) 2295
anti-ulcer agents - therapeutic use (2273) 2273
bacterial proteins - genetics (2233) 2233
peptic ulcer (2168) 2168
gastritis - pathology (2130) 2130
campylobacter-pylori (2093) 2093
case-control studies (2073) 2073
polymerase chain reaction (2055) 2055
medicine & public health (1995) 1995
association (1978) 1978
gastroenterology (1971) 1971
peptic ulcer - microbiology (1961) 1961
carcinoma (1955) 1955
endoscopy (1936) 1936
gastrointestinal diseases (1902) 1902
ulcers (1899) 1899
biochemistry & molecular biology (1857) 1857
pathology (1837) 1837
child, preschool (1834) 1834
clarithromycin (1823) 1823
young adult (1823) 1823
sensitivity and specificity (1819) 1819
proton pump inhibitors (1817) 1817
therapy (1816) 1816
helicobacter infections - metabolism (1810) 1810
omeprazole (1799) 1799
population (1767) 1767
chronic disease (1759) 1759
antibodies, bacterial - blood (1758) 1758
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (34) 34
Online Resources - Online (19) 19
Collection Dvlpm't (Acquisitions) - Closed Orders (6) 6
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
St. Michael's Hospital - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (56266) 56266
Japanese (1103) 1103
Spanish (854) 854
German (746) 746
Korean (730) 730
Russian (697) 697
French (692) 692
Chinese (555) 555
Polish (286) 286
Portuguese (164) 164
Italian (115) 115
Turkish (94) 94
Czech (69) 69
Hungarian (67) 67
Swedish (64) 64
Danish (52) 52
Persian (46) 46
Croatian (41) 41
Ukrainian (36) 36
Dutch (35) 35
Norwegian (22) 22
Serbian (21) 21
Romanian (19) 19
Finnish (15) 15
Hebrew (13) 13
Slovak (12) 12
Slovenian (9) 9
Arabic (6) 6
Lithuanian (6) 6
Bulgarian (5) 5
Bosnian (4) 4
Icelandic (3) 3
Indonesian (1) 1
Latin (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 04/2010, Volume 362, Issue 17, pp. 1597 - 1604
Journal Article
2002, Infectious agents and pathogenesis., ISBN 9780306466588, xxviii, 286
Book
Gut, ISSN 0017-5749, 01/2017, Volume 66, Issue 1, pp. 6 - 30
Important progress has been made in the management of Helicobacter pylori infection and in this fifth edition of the Maastricht Consensus Report, key aspects... 
CONTAINING QUADRUPLE THERAPY | STANDARD TRIPLE THERAPY | RANDOMIZED-CONTROLLED-TRIALS | C-13-UREA BREATH TEST | LOW-DOSE ASPIRIN | GASTROESOPHAGEAL-REFLUX DISEASE | PROTON-PUMP INHIBITOR | GASTRIC-CANCER RISK | DUODENAL-ULCER PATIENTS | GASTROENTEROLOGY & HEPATOLOGY | 3RD-LINE RESCUE THERAPY | Humans | Helicobacter Infections - prevention & control | Drug Resistance, Bacterial | Helicobacter Infections - complications | Bismuth - therapeutic use | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Nitroimidazoles - therapeutic use | Helicobacter pylori | Helicobacter Infections - drug therapy | Gastritis - microbiology | Helicobacter Infections - diagnosis | Drug Therapy, Combination | Stomach Neoplasms - diagnosis | Early Detection of Cancer | Risk Factors | Gastrointestinal Microbiome | Fluoroquinolones - therapeutic use | Clarithromycin - therapeutic use | Dyspepsia - microbiology | Gastroscopy | Evidence-Based Medicine | Proton Pump Inhibitors - therapeutic use | Stomach Neoplasms - microbiology | Amoxicillin - therapeutic use | Stomach - microbiology | Practice Guidelines as Topic | Helicobacter infections | Care and treatment | Wellness programs | Usage | Working groups | Systematic review | Staphylococcus infections | Management | Stomach cancer | Delphi method | Meta-analysis | Probiotics | Microbiota | Infectious diseases | Antibiotics | Ulcers | Patient satisfaction | Public health | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Gastroenterology and Hepatology (Australia), ISSN 0815-9319, 2009, Volume 24, Issue 10, pp. 1587 - 1600
The Asia-Pacific Consensus Conference was convened to review and synthesize the most current information on Helicobacter pylori management so as to update the... 
Helicobacter pylori:treatment and antimicrobial resistance | H. pylori and gastric cancer | Helicobacter pylori:diagnosis | C-13-UREA BREATH TEST | helicobacter pylori:diagnosis | helicobacter pylori:treatment and antimicrobial resistance | RIFABUTIN TRIPLE THERAPY | LOW-DOSE ASPIRIN | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | GASTROESOPHAGEAL-REFLUX DISEASE | VS. QUADRUPLE THERAPY | 2ND-LINE TREATMENT | ERADICATION THERAPY | DUODENAL-ULCER PATIENTS | GASTROENTEROLOGY & HEPATOLOGY | PEPTIC-ULCER | Predictive Value of Tests | Helicobacter Infections - ethnology | Humans | Breath Tests | Drug Resistance, Bacterial | Helicobacter Infections - complications | Treatment Outcome | Evidence-Based Medicine | Proton Pump Inhibitors - therapeutic use | Helicobacter Infections - therapy | Anti-Bacterial Agents - therapeutic use | Asia - epidemiology | Asian Continental Ancestry Group | Helicobacter pylori - isolation & purification | Microbiological Techniques | Helicobacter Infections - diagnosis | Drug Therapy, Combination | Helicobacter Infections - microbiology | Gastroesophageal reflux | Medical colleges | Drug resistance in microorganisms | Aspirin | Care and treatment | Anemia | Antidiarrheals | Cytochrome P-450 | Practice guidelines (Medicine) | Peptic ulcer | Antiulcer drugs | Prevention | Helicobacter pylori | Amoxicillin | Lymphomas | Health aspects | Smoking | Cancer | Index Medicus
Journal Article
04/2013
Background: Helicobacter pylori-infection associated gastritis is known to be a significant risk factor of gastric cancer. Serum levels of Gastrin-17 and... 
Helicobacter pylori | atrophic gastritis | pepsinogen | gastrin
Web Resource
BioMed Research International, ISSN 2314-6133, 2015, Volume 2015, pp. 278308 - 278308
  Several strategies including sequential, concomitant, and hybrid therapies are therefore proposed to increase the eradication rate of first-line treatment... 
MEDICINE, RESEARCH & EXPERIMENTAL | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | Helicobacter Infections - pathology | Humans | Helicobacter pylori - pathogenicity | Helicobacter Infections - microbiology | Health care | Hospitals | Antibiotics | Internal medicine | Ulcers | Colleges & universities | Gastroenterology | Infections | Stomach cancer | Index Medicus
Journal Article
Gut, ISSN 0017-5749, 05/2013, Volume 62, Issue 5, pp. 676 - 682
Objective To evaluate the benefit of mass eradication of Helicobacter pylori infection in reducing premalignant gastric lesions. Design Mass eradication of H... 
COST-EFFECTIVENESS ANALYSIS | DESIGN | TAIWAN | ENDOSCOPIC RESECTION | MARKOV MODEL | RISK | CLASSIFICATION | THERAPIES | RANDOMIZED CONTROLLED-TRIAL | GASTROENTEROLOGY & HEPATOLOGY | CARCINOMA | Metaplasia - microbiology | Recurrence | Prevalence | Follow-Up Studies | Humans | Middle Aged | Peptic Ulcer - prevention & control | Helicobacter pylori - drug effects | Male | Multiphasic Screening | Incidence | Anti-Bacterial Agents - therapeutic use | Peptic Ulcer - microbiology | Helicobacter Infections - drug therapy | Adult | Female | Helicobacter Infections - diagnosis | Drug Therapy, Combination | Odds Ratio | Anti-Ulcer Agents - therapeutic use | Risk Factors | Breath Tests | Helicobacter Infections - epidemiology | Treatment Outcome | Clarithromycin - therapeutic use | Stomach Neoplasms - microbiology | Algorithms | Stomach Neoplasms - prevention & control | Taiwan - epidemiology | Metaplasia - prevention & control | Precancerous Conditions - microbiology | Precancerous Conditions - prevention & control | Prevention | Helicobacter infections | Research | Stomach cancer | Disease prevention | Studies | Surveillance | Disease | Ulcers | Mortality | Sanitation | Infections | Endoscopy | Index Medicus | Abridged Index Medicus | molecular oncology | colonic neoplasms | colorectal adenomas | cancer prevention | gastric lymphoma | helicobacter pylori - pathogenesis | cancer registries | oesophageal cancer | colonic polyps | chemoprevention | Helicobacter Pylori | colorectal cancer screening | endoscopic polypectomy | colonoscopy | colorectal neoplasia | gastric cancer | meta-analysis | endoscopy | gastro-oesophageal reflux disease | endoscopic procedures | colorectal neoplasm | cancer epidemiology | 1506 | gastrointestinal neoplasia | statistics
Journal Article
Journal Article
Journal of Gastroenterology and Hepatology, ISSN 0815-9319, 01/2019, Volume 34, Issue 1, pp. 120 - 123
Journal Article
WIENER KLINISCHE WOCHENSCHRIFT, ISSN 0043-5325, 09/2018, Volume 130, Issue 17-18, pp. 530 - 534
Helicobacter pylori infections represent an important factor in the pathogenesis of chronic gastritis, peptic ulcer, MALT lymphoma and gastric adenocarcinoma.... 
ANTIMICROBIAL SUSCEPTIBILITY | TESTS | MANAGEMENT | C-13-UREA BREATH TEST | RAPID UREASE TEST | GASTRITIS | Invasive test | ACCURACY | BIOPSY SITES | MEDICINE, GENERAL & INTERNAL | THERAPY | Helicobacter pylori | Diagnosis | Non-invasive test | STOOL ANTIGEN TEST
Journal Article
17.